Utilidad del bevacizumab en sangrado gastrointestinal crónico en telangiectasia hemorrágica hereditaria
Main Authors: | A. Gutiérrez-Macías, I. Barroso-Benayos, A. Burzako-Sánchez |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Elsevier
2023-10-01
|
Series: | Revista de Gastroenterología de México |
Online Access: | http://www.sciencedirect.com/science/article/pii/S037509062300054X |
Similar Items
-
Utility of bevacizumab in chronic gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
by: A. Gutiérrez-Macías, et al.
Published: (2023-10-01) -
Uso de bevacizumab en la telangiectasia hemorrágica hereditaria: reporte de caso
by: Darío González Viñas, et al.
Published: (2022-06-01) -
Compromiso hepático en la telangiectasia hemorrágica hereditaria
by: María Marta Piskorz, et al.
Published: (2011-01-01) -
Telangiectasia hemorrágica hereditária: resposta hematológica após terapêutica com talidomida
by: Eduardo Ribeiro, et al.
Published: (2013-03-01) -
Telangiectasia Hemorrágica Hereditária: Proposta de Protocolo de Referenciação Interdisciplinar
by: Isabel Costa, et al.
Published: (2021-12-01)